Triazole-derived kinase inhibitors and uses thereof

Details Triazole-derived kinase inhibitors and uses thereof Triazole-derived kinase inhibitors and uses thereof

Filed on

2005-11-08

Date issued

2005-11-08

Examiner

Richter, Johann (Department: 1621)

Patent Class

Drug, bio-affecting and body treating compositions

SubClass

Designated organic active ingredient containing

SubSubClass

Having -c-, wherein x is chalcogen, bonded directly to...

Other Related Categories

C514S359000, C514S383000, C548S225000, C548S264800, C548S250000, C548S256000, C548S127000, C544S343000, C544S336000, C544S345000, C544S106000

Type

Reexamination Certificate

Status

active

Patent number

06962936

Description

ABSTRACT:
Described herein are compounds that are useful as protein kinase inhibitors having the formula:where Ht, R2, T, and m are as described in the specification. The compounds are useful for treating diseases in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease.

REFERENCES:
patent: WO 95/31451 (1995-11-01), None
patent: WO 98/52941 (1998-11-01), None
patent: WO 01/56993 (2001-08-01), None
Dornow et al., Chemische Berichte 1958, 91, 1841-1851.
Aykut et al., A Quantum-Chemical Study on3,3′-bi(1,2,4-Triazole), Models in Chemistry, 133, 1-2, pp 43-51, 1996.

Affiliated with

Also associated with

Rating

Triazole-derived kinase inhibitors and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Triazole-derived kinase inhibitors and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazole-derived kinase inhibitors and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3521260